Genocea Biosciences (GNCA) Tops Q4 EPS by 12c; Announces Diantha Duvall as New CFO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Genocea Biosciences (GNCA) Tops Q4 EPS by 12c; Announces Diantha Duvall as New CFO

Genocea Biosciences (GNCA) PT Lowered to $2 at Needham & Company

March 1, 2019 8:01 AM EST

Needham & Company analyst Chad Messer lowered the price target on Genocea Biosciences (NASDAQ: GNCA) to $2.00 (from $3.00) while maintaining a Buy rating.

Messer commetned, "Genocea ended 2018 with $26.4M. On February 12th the company announced a flexible private placement adding up to $39.2M to the... More

Genocea Biosciences (GNCA) PT Raised to $5.75 at H.C. Wainwright

February 28, 2019 11:55 AM EST

H.C. Wainwright analyst Joseph Pantginis raised the price target on Genocea Biosciences (NASDAQ: GNCA) to $5.75 (from $5.00) while maintaining a Buy rating following results.

Pantginis said the initial immunogenicity data of GEN-009 remains key catalyst for shares.

"Readout of... More